1st Central European Conference for Advanced Therapy and Immunotherapy. Book of Abstracts : Rare Diseases Need Innovative Therapies — Innovative Therapies Need Scientific Discoveries
This gathering brings together leading minds from academia, clinical sites, and research institutions across Central Europe to address shared challenges in rare diseases and advanced therapies. The European Union estimates that between 6,000 and 8,000 rare diseases affect approximately 30 million pe...
| Autores principales: | , , |
|---|---|
| Formato: | Libro |
| Publicado: |
Masaryk University
2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=nlebk&AN=4296767&site=ehost-live header: @attributes: shortDbName: nlebk uiTerm: 4296767 longDbName: eBook Collection (EBSCOhost) uiTag: AN controlInfo: bkinfo: btl: 1st Central European Conference for Advanced Therapy and Immunotherapy. Book of Abstracts : Rare Diseases Need Innovative Therapies — Innovative Therapies Need Scientific Discoveries aug: au: Salačová, Markéta Pospíšilová, Lucie Vladíková, Hana isbn: 9788028006525 imageinfo: pubinfo: dt: @attributes: year: 2024 month: 01 day: 01 pub: Masaryk University pubContract: Masaryk University Press place: [S.l.] price: 0.01 limitsGroup: maxCheckoutDays: 1500 pda: N printPagesOffline: 100 printPagesOnline: 100 previewPages: 10000 artinfo: ui: 4296767 1549623607 formats: fmt: @attributes: type: EB doid: NL$4296767$PDF caption: PDF download: Y tig: atl: 1st Central European Conference for Advanced Therapy and Immunotherapy. Book of Abstracts : Rare Diseases Need Innovative Therapies — Innovative Therapies Need Scientific Discoveries ptl: 1st Central European Conference for Advanced Therapy and Immunotherapy. Book of Abstracts aug: au: Salačová, Markéta Pospíšilová, Lucie Vladíková, Hana sug: subj: MEDICAL / Diseases ab: This gathering brings together leading minds from academia, clinical sites, and research institutions across Central Europe to address shared challenges in rare diseases and advanced therapies. The European Union estimates that between 6,000 and 8,000 rare diseases affect approximately 30 million people across the region, representing around 6-8% of the population. These conditions are often chronic, progressive, and life-threatening, significantly impacting patients'quality of life. On a local level, over half a million people in the Czech R. alone are affected by rare diseases. Despite these numbers, many patients are still waiting for an accurate diagnosis. The number of newly identified rare diseases continues to rise, alongside well-known challenges such as delays in diagnosis. The leading experts in Advanced Therapy Medicinal Products (ATMPs) from the European Union (EU) are significantly contributing to research across the entire ATMP life-cycle. These contributions span multiple stages, from initial discovery and development to clinical trials, manufacturing, regulation, and post-market surveillance. Their research addresses key challenges in the field, such as improving the efficacy, safety, and scalability of gene therapies, cell therapies, and tissue-engineered products. pubtype: eBook doctype: Book ougenre: Book language: English copyright: @attributes: flag: N copyrightText: holdings: @attributes: islocal: N |
|---|